Regeneron Pharmaceuticals | REGN - Pasivo Circulante

Precio De Mercado
745.77
Cambio Diario
-0.84 -0.11%
Mensual
-6.02%
Anual
11.83%
Q1 Expectativa
736.91




Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Agenus USD 287.13M 52.57M 2025-09
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Astellas Pharma JPY 1.32T 873M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Biogen USD 3.35B 59.4M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
J&J USD 54.13B 3.26B 2025-12
Kyowa Hakko Kirin JPY 181.08B 4.08B 2025-12
Merck USD 28.63B 2.59B 2025-09
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 32B 286M 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 9.32B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
United Therapeutics USD 560.6M 14.3M 2025-12
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12